How do we measure the costs, benefits, and harms of sharing data from biomedical studies? A protocol for a scoping review [version 2; peer review: 2 approved]
Introduction The benefits of sharing participant-level data, including clinical or epidemiological data, genomic data, high-dimensional imaging data, or human-derived samples, from biomedical studies have been widely touted and may be taken for granted. As investments in data sharing and reuse effor...
Saved in:
| Main Authors: | Lauren Maxwell, Ankur Krishnan, Priya Shreedhar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2025-01-01
|
| Series: | Open Research Europe |
| Subjects: | |
| Online Access: | https://open-research-europe.ec.europa.eu/articles/3-151/v2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimicrobial Stewardship in Ireland (2010-2021): a scoping review protocol [version 2; peer review: 2 approved]
by: Olive Murphy, et al.
Published: (2025-01-01) -
Ethical issues in biomedical research in Nigeria: a systematic review
by: Chinaza Richard Ikeagwulonu, et al.
Published: (2021-03-01) -
Analysis of Common Ethical Review Issues in Biomedical Research in Medical Universities
by: Hui JIANG, et al.
Published: (2025-02-01) -
Role, function, and expectations of research funding committees: Perspectives from committee members [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved]
by: Amanda Blatch-Jones, et al.
Published: (2025-01-01) -
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
by: Breanne Stewart, et al.
Published: (2025-02-01)